Artificial intelligence is changing healthcare. And that might include how MS will be diagnosed, treated, and managed. It’s even beginning to impact the way some MS research is being conducted. Chase Spurlock, PhD, founder and CEO of IQuity talks about how IQuity is using its expertise in machine learning to improve patient care, drive the creation of new therapies, and reduce the costs associated with managing chronic illness, including multiple sclerosis.

Listen to the Podcast